Heights Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSIW
Heights Capital Management's TLSIW Position: Q1 2022 in Review
Heights Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2022, closing a stake of 83,333 shares — an estimated $43K sold.
Heights Capital Management first reported a position in TLSIW in Q1 2021 and held it in 4 quarters. The position peaked at $92K in Q1 2021. 26 funds tracked by Wall St. Rank hold TLSIW as of Q1 2022.
- Heights Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q1 2022 after selling out during the quarter.
- Heights Capital Management sold 83,333 TriSalus Life Sciences Warrant shares in Q1 2022, an estimated $43K.
- Heights Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 4 quarters.
- Heights Capital Management's TriSalus Life Sciences Warrant position peaked at $92K in Q1 2021.
- 26 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2022.
Based on Heights Capital Management's 13F filing for Q1 2022, filed 16 May 2022.